Advertisement

Index by author

September 01, 1998; Volume 286,Issue 3

A

  1. Aguirre, Norberto

    1. The Role of Dopaminergic Systems in the Perinatal Sensitivity to 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rats
      Norberto Aguirre, Meritxell Barrionuevo, Berta Lasheras and Joaquín Del Río
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1159-1165;

  2. Albinus, Margitta

    1. Effect of KATP Channel Blocker U37883A on Renal Function in Experimental Diabetes Mellitus in Rats
      Volker Vallon, Margitta Albinus and Doreen Blach
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1215-1221;

  3. Aldasoro, Martín

    1. Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
      Gloria Segarra, Pascual Medina, Cristina Domenech, José M. Vila, Juan B. Martínez-León, Martín Aldasoro and Salvador Lluch
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1315-1320;

  4. Althoff, A.

    1. Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs
      L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger and W. Seeger
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1309-1314;

  5. An, Songzhu

    1. EP4/EP2 Receptor-Specific Prostaglandin E2 Regulation of Interleukin-6 Generation by Human HSB.2 Early T Cells
      Li Zeng, Songzhu An and Edward J. Goetzl
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1420-1426;

  6. Andoh, Tsugunobu

    1. Substance P Induction of Itch-Associated Response Mediated by Cutaneous NK1 Tachykinin Receptors in Mice
      Tsugunobu Andoh, Tetsuro Nagasawa, Masamichi Satoh and Yasushi Kuraishi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1140-1145;

  7. Audinot, Valérie

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;

  8. Avoli, Massimo

    1. Modulation of Epileptiform Activity by Adenosine A1 Receptor-Mediated Mechanisms in the Juvenile Rat Hippocampus
      Virginia Tancredi, Margherita D’Antuono, Astrid Nehlig and Massimo Avoli
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1412-1419;

  9. Ayajiki, Kazuhide

    1. Modifications by Superoxide-Generating Agent, Neurotransmitters and Neuromodulators of Nitroxidergic Nerve Function in Monkey Cerebral Arteries
      Tomio Okamura, Hideyuki Fujioka, Kazuhide Ayajiki and Noboru Toda
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1321-1325;

B

  1. Baghdoyan, H. A.

    1. M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in the Medial Pontine Reticular Formation
      H. A. Baghdoyan, R. Lydic and M. A. Fleegal
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1446-1452;

  2. Balducci, Claudia

    1. Characterization of the Effects of the Partial Dopamine Agonist Terguride on Cocaine Self-Administration in the Rat
      Luigi Pulvirenti, Claudia Balducci, Marla Piercy and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1231-1238;

  3. Barrionuevo, Meritxell

    1. The Role of Dopaminergic Systems in the Perinatal Sensitivity to 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rats
      Norberto Aguirre, Meritxell Barrionuevo, Berta Lasheras and Joaquín Del Río
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1159-1165;

  4. Bartolini, Alessandro

    1. Role of 5-HT4 Receptors in the Mouse Passive Avoidance Test
      Nicoletta Galeotti, Carla Ghelardini and Alessandro Bartolini
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1115-1121;

  5. Battaglia, George

    1. Prenatal Exposure to Fluoxetine (Prozac) Produces Site-Specific and Age-Dependent Alterations in Brain Serotonin Transporters in Rat Progeny: Evidence from Autoradiographic Studies
      Theresa M. Cabrera-Vera and George Battaglia
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1474-1481;

  6. Benhamou, Simone

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  7. Bervoets, Karin

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  8. Bespalov, Anton Y.

    1. Effects of N-Methyl-d-Aspartate Receptor Antagonists on Discriminative Stimulus Effects of Naloxone in Morphine-Dependent Rats Using the Y-Maze Drug Discrimination Paradigm ,
      Ivan O. Medvedev, Olga A. Dravolina and Anton Y. Bespalov
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1260-1268;

  9. Bhamre, Shubhada

    1. Serotonin-Mediated Palmitoylation and Depalmitoylation of GAlpha Proteins in Rat Brain Cortical Membranes
      Shubhada Bhamre, Hoau-Yan Wang and Eitan Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1482-1489;

  10. Billman, George E.

    1. HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part II: Effects on Susceptibility to Ventricular Fibrillation Induced by Myocardial Ischemia in Conscious Dogs
      George E. Billman, Heinrich C. Englert and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1465-1473;

  11. Blach, Doreen

    1. Effect of KATP Channel Blocker U37883A on Renal Function in Experimental Diabetes Mellitus in Rats
      Volker Vallon, Margitta Albinus and Doreen Blach
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1215-1221;

  12. Black, Matthew L.

    1. Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Pentazocine and Morphine in Normal Volunteers
      James P. Zacny, Joanna L. Hill, Matthew L. Black and Parvine Sadeghi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1197-1207;

  13. Blaisdell, Joyce

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  14. Blier, Pierre

    1. Full Agonistic Properties of Bay x 3702 on Presynaptic and Postsynaptic 5-HT1A Receptors Electrophysiological Studies in the Rat Hippocampus and Dorsal Raphe.
      Jianming Dong, Claude de Montigny and Pierre Blier
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1239-1247;

  15. Bouchardy, Christine

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  16. Bozarth, Jeffrey M.

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  17. Brierley, Matthew J.

    1. Potentiation and Inhibition of Nicotinic Acetylcholine Receptors by Spermine in the TE671 Human Muscle Cell Line
      Zuoyi Shao, Ian R. Mellor, Matthew J. Brierley, John Harris and Peter N. R. Usherwood
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1269-1276;

  18. Brocco, Mauricette

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  19. Brooks, David P.

    1. CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
      Miklos Gellai, George F. Schreiner, Robert R. Ruffolo, Tracey Fletcher, Robin DeWolf and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1191-1196;

  20. Brynne, Lena

    1. Concentration-Effect Relationship of l-Propranolol and Metoprolol in Spontaneous Hypertensive Rats after Exercise-Induced Tachycardia
      Lena Brynne, Mats O. Karlsson and Lennart K. Paalzow
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1152-1158;

  21. Burke, Trisha

    1. Interaction of 2′,2′-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells
      Trisha Burke, Stephanie Lee, Peter J. Ferguson and James R. Hammond
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1333-1340;

C

  1. Cabrera-Vera, Theresa M.

    1. Prenatal Exposure to Fluoxetine (Prozac) Produces Site-Specific and Age-Dependent Alterations in Brain Serotonin Transporters in Rat Progeny: Evidence from Autoradiographic Studies
      Theresa M. Cabrera-Vera and George Battaglia
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1474-1481;

  2. Camerino, Claudia

    1. Chronic Administration of Taurine to Aged Rats Improves the Electrical and Contractile Properties of Skeletal Muscle Fibers
      Sabata Pierno, Annamaria De Luca, Claudia Camerino, Ryan J. Huxtable and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1183-1190;

  3. Camerino, Diana Conte

    1. Chronic Administration of Taurine to Aged Rats Improves the Electrical and Contractile Properties of Skeletal Muscle Fibers
      Sabata Pierno, Annamaria De Luca, Claudia Camerino, Ryan J. Huxtable and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1183-1190;

  4. Chambers, Howard W.

    1. Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon
      Amber L. Pond, Howard W. Chambers, Cody P. Coyne and Janice E. Chambers
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1404-1411;

  5. Chambers, Janice E.

    1. Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon
      Amber L. Pond, Howard W. Chambers, Cody P. Coyne and Janice E. Chambers
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1404-1411;

  6. Chiba, Kan

    1. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes
      Takashi Kawashiro, Kouwa Yamashita, Xue-Jun Zhao, Eriko Koyama, Masayoshi Tani, Kan Chiba and Takashi Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1294-1300;

  7. Cook, Michael A.

    1. Hydrogen Peroxide-Induced Stimulation of L-Type Calcium Current in Guinea Pig Ventricular Myocytes and Its Inhibition by Adenosine A1 Receptor Activation
      George P. Thomas, Stephen M. Sims, Michael A. Cook and Morris Karmazyn
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1208-1214;

  8. Coyne, Cody P.

    1. Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon
      Amber L. Pond, Howard W. Chambers, Cody P. Coyne and Janice E. Chambers
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1404-1411;

  9. Cussac, Didier

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;

D

  1. D’Antuono, Margherita

    1. Modulation of Epileptiform Activity by Adenosine A1 Receptor-Mediated Mechanisms in the Juvenile Rat Hippocampus
      Virginia Tancredi, Margherita D’Antuono, Astrid Nehlig and Massimo Avoli
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1412-1419;

  2. Dayer, Pierre

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  3. Dekeyne, Anne

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  4. Del Río, Joaquín

    1. The Role of Dopaminergic Systems in the Perinatal Sensitivity to 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rats
      Norberto Aguirre, Meritxell Barrionuevo, Berta Lasheras and Joaquín Del Río
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1159-1165;

  5. De Luca, Annamaria

    1. Chronic Administration of Taurine to Aged Rats Improves the Electrical and Contractile Properties of Skeletal Muscle Fibers
      Sabata Pierno, Annamaria De Luca, Claudia Camerino, Ryan J. Huxtable and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1183-1190;

  6. de Montigny, Claude

    1. Full Agonistic Properties of Bay x 3702 on Presynaptic and Postsynaptic 5-HT1A Receptors Electrophysiological Studies in the Rat Hippocampus and Dorsal Raphe.
      Jianming Dong, Claude de Montigny and Pierre Blier
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1239-1247;

  7. de Vrueh, Remco L. A.

    1. Transport of l-Valine-Acyclovir Via the Oligopeptide Transporter In The Human Intestinal Cell Line, Caco-2
      Remco L. A. de Vrueh, Philip L. Smith and Chao-Pin Lee
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1166-1170;

  8. DeWolf, Robin

    1. CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
      Miklos Gellai, George F. Schreiner, Robert R. Ruffolo, Tracey Fletcher, Robin DeWolf and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1191-1196;

  9. Dintaman, Jay M.

    1. Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein
      Annice E. Kim, Jay M. Dintaman, David S. Waddell and Jeffrey A. Silverman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1439-1445;

  10. Domenech, Cristina

    1. Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
      Gloria Segarra, Pascual Medina, Cristina Domenech, José M. Vila, Juan B. Martínez-León, Martín Aldasoro and Salvador Lluch
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1315-1320;

  11. Dong, Jianming

    1. Full Agonistic Properties of Bay x 3702 on Presynaptic and Postsynaptic 5-HT1A Receptors Electrophysiological Studies in the Rat Hippocampus and Dorsal Raphe.
      Jianming Dong, Claude de Montigny and Pierre Blier
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1239-1247;

  12. Dravolina, Olga A.

    1. Effects of N-Methyl-d-Aspartate Receptor Antagonists on Discriminative Stimulus Effects of Naloxone in Morphine-Dependent Rats Using the Y-Maze Drug Discrimination Paradigm ,
      Ivan O. Medvedev, Olga A. Dravolina and Anton Y. Bespalov
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1260-1268;

E

  1. Ekins, Sean

    1. Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
      Sean Ekins, Mark Vandenbranden, Barbara J. Ring, Jennifer S. Gillespie, Tian J. Yang, Harry V. Gelboin and Steven A. Wrighton
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1253-1259;

  2. Englert, Heinrich C.

    1. HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part I: Effects on Cardiomyocytes, Coronary Flow and Pancreatic β-Cells
      Heinz Gögelein, Jens Hartung, Heinrich C. Englert and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1453-1464;
    2. HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part II: Effects on Susceptibility to Ventricular Fibrillation Induced by Myocardial Ischemia in Conscious Dogs
      George E. Billman, Heinrich C. Englert and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1465-1473;

  3. Ermert, L.

    1. Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs
      L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger and W. Seeger
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1309-1314;

  4. Ermert, M.

    1. Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs
      L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger and W. Seeger
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1309-1314;

F

  1. Ferguson, Peter J.

    1. Interaction of 2′,2′-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells
      Trisha Burke, Stephanie Lee, Peter J. Ferguson and James R. Hammond
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1333-1340;

  2. Fleegal, M. A.

    1. M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in the Medial Pontine Reticular Formation
      H. A. Baghdoyan, R. Lydic and M. A. Fleegal
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1446-1452;

  3. Fletcher, Tracey

    1. CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
      Miklos Gellai, George F. Schreiner, Robert R. Ruffolo, Tracey Fletcher, Robin DeWolf and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1191-1196;

  4. Florian, Jennifer A.

    1. Dissociation of Angiotensin II-Stimulated Activation of Mitogen-Activated Protein Kinase Kinase from Vascular Contraction
      Stephanie W. Watts, Jennifer A. Florian and Kimberly M. Monroe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1431-1438;

  5. Forsythe, Mark S.

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  6. Friedman, Eitan

    1. Serotonin-Mediated Palmitoylation and Depalmitoylation of GAlpha Proteins in Rat Brain Cortical Membranes
      Shubhada Bhamre, Hoau-Yan Wang and Eitan Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1482-1489;

  7. Friedman, Paul A.

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  8. Fujino, Masayuki A.

    1. Inhibitory Effects of Nitric Oxide Donors on Nitric Oxide Synthesis in Rat Gastric Myenteric Plexus
      Kenji Hosoda, Toku Takahashi, Masayuki A. Fujino and Chung Owyang
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1222-1230;

  9. Fujioka, Hideyuki

    1. Modifications by Superoxide-Generating Agent, Neurotransmitters and Neuromodulators of Nitroxidergic Nerve Function in Monkey Cerebral Arteries
      Tomio Okamura, Hideyuki Fujioka, Kazuhide Ayajiki and Noboru Toda
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1321-1325;

  10. Fulton, David

    1. Evidence against Anandamide as the Hyperpolarizing Factor Mediating the Nitric Oxide-Independent Coronary Vasodilator Effect of Bradykinin in the Rat
      David Fulton and John Quilley
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1146-1151;

G

  1. Galeotti, Nicoletta

    1. Role of 5-HT4 Receptors in the Mouse Passive Avoidance Test
      Nicoletta Galeotti, Carla Ghelardini and Alessandro Bartolini
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1115-1121;

  2. Gebhardt, Rolf

    1. Inhibition of Cholesterol Biosynthesis in Primary Cultured Rat Hepatocytes by Artichoke (Cynara scolymus L.) Extracts
      Rolf Gebhardt
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1122-1128;

  3. Gelboin, Harry V.

    1. Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
      Sean Ekins, Mark Vandenbranden, Barbara J. Ring, Jennifer S. Gillespie, Tian J. Yang, Harry V. Gelboin and Steven A. Wrighton
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1253-1259;

  4. Gellai, Miklos

    1. CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
      Miklos Gellai, George F. Schreiner, Robert R. Ruffolo, Tracey Fletcher, Robin DeWolf and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1191-1196;

  5. Ghanayem, Burhan I.

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  6. Ghelardini, Carla

    1. Role of 5-HT4 Receptors in the Mouse Passive Avoidance Test
      Nicoletta Galeotti, Carla Ghelardini and Alessandro Bartolini
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1115-1121;

  7. Gillespie, Jennifer S.

    1. Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
      Sean Ekins, Mark Vandenbranden, Barbara J. Ring, Jennifer S. Gillespie, Tian J. Yang, Harry V. Gelboin and Steven A. Wrighton
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1253-1259;

  8. Gobert, Alain

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;

  9. Goetzl, Edward J.

    1. EP4/EP2 Receptor-Specific Prostaglandin E2 Regulation of Interleukin-6 Generation by Human HSB.2 Early T Cells
      Li Zeng, Songzhu An and Edward J. Goetzl
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1420-1426;

  10. Gögelein, Heinz

    1. HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part I: Effects on Cardiomyocytes, Coronary Flow and Pancreatic β-Cells
      Heinz Gögelein, Jens Hartung, Heinrich C. Englert and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1453-1464;

  11. Goldstein, Joyce A.

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  12. Grimminger, F.

    1. Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs
      L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger and W. Seeger
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1309-1314;

H

  1. Hammond, James R.

    1. Interaction of 2′,2′-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells
      Trisha Burke, Stephanie Lee, Peter J. Ferguson and James R. Hammond
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1333-1340;

  2. Harris, John

    1. Potentiation and Inhibition of Nicotinic Acetylcholine Receptors by Spermine in the TE671 Human Muscle Cell Line
      Zuoyi Shao, Ian R. Mellor, Matthew J. Brierley, John Harris and Peter N. R. Usherwood
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1269-1276;

  3. Hartung, Jens

    1. HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part I: Effects on Cardiomyocytes, Coronary Flow and Pancreatic β-Cells
      Heinz Gögelein, Jens Hartung, Heinrich C. Englert and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1453-1464;

  4. Hill, Joanna L.

    1. Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Pentazocine and Morphine in Normal Volunteers
      James P. Zacny, Joanna L. Hill, Matthew L. Black and Parvine Sadeghi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1197-1207;

  5. Hosoda, Kenji

    1. Inhibitory Effects of Nitric Oxide Donors on Nitric Oxide Synthesis in Rat Gastric Myenteric Plexus
      Kenji Hosoda, Toku Takahashi, Masayuki A. Fujino and Chung Owyang
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1222-1230;

  6. Huang, X.-P.

    1. Pharmacological Characterization of Human m1 Muscarinic Acetylcholine Receptors with Double Mutations at the Junction of TM VI and the Third Extracellular Domain
      X.-P. Huang, F. E. Williams, S. M. Peseckis and W. S. Messer
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1129-1139;

  7. Huffman, John W.

    1. Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A
      Sandra P. Welch, John W. Huffman and John Lowe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1301-1308;

  8. Huxtable, Ryan J.

    1. Chronic Administration of Taurine to Aged Rats Improves the Electrical and Contractile Properties of Skeletal Muscle Fibers
      Sabata Pierno, Annamaria De Luca, Claudia Camerino, Ryan J. Huxtable and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1183-1190;

I

  1. Ibeanu, Gordon C.

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  2. Imura, Nobumasa

    1. Protective Effect of Bismuth Nitrate Against Injury to the Bone Marrow by γ-Irradiation in Mice: Possible Involvement of Induction of Metallothionein Synthesis
      Nobuhiko Miura, Masahiko Satoh, Nobumasa Imura and Akira Naganuma
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1427-1430;

  3. Ishizaki, Takashi

    1. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes
      Takashi Kawashiro, Kouwa Yamashita, Xue-Jun Zhao, Eriko Koyama, Masayoshi Tani, Kan Chiba and Takashi Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1294-1300;

K

  1. Kalivas, P. W.

    1. Calcium-Mediated Second Messengers Modulate the Expression of Behavioral Sensitization to Cocaine
      R. C. Pierce, E. A. Quick, D. C. Reeder, Z. R. Morgan and P. W. Kalivas
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1171-1176;

  2. Karlsson, Mats O.

    1. Concentration-Effect Relationship of l-Propranolol and Metoprolol in Spontaneous Hypertensive Rats after Exercise-Induced Tachycardia
      Lena Brynne, Mats O. Karlsson and Lennart K. Paalzow
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1152-1158;

  3. Karmazyn, Morris

    1. Hydrogen Peroxide-Induced Stimulation of L-Type Calcium Current in Guinea Pig Ventricular Myocytes and Its Inhibition by Adenosine A1 Receptor Activation
      George P. Thomas, Stephen M. Sims, Michael A. Cook and Morris Karmazyn
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1208-1214;

  4. Kawashiro, Takashi

    1. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes
      Takashi Kawashiro, Kouwa Yamashita, Xue-Jun Zhao, Eriko Koyama, Masayoshi Tani, Kan Chiba and Takashi Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1294-1300;

  5. Kim, Annice E.

    1. Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein
      Annice E. Kim, Jay M. Dintaman, David S. Waddell and Jeffrey A. Silverman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1439-1445;

  6. Klein, J. T.

    1. Application of Liquid Chromatography/Mass Spectrometry in Accelerating the Identification of Human Liver Cytochrome P450 Isoforms Involved in the Metabolism of Iloperidone
      A. E. Mutlib and J. T. Klein
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1285-1293;

  7. Koob, George F.

    1. Characterization of the Effects of the Partial Dopamine Agonist Terguride on Cocaine Self-Administration in the Rat
      Luigi Pulvirenti, Claudia Balducci, Marla Piercy and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1231-1238;

  8. Kouda, Tomoko

    1. Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
      Hikaru Yabuuchi, Ikumi Tamai, Kyoko Morita, Tomoko Kouda, Ken-Ichi Miyamoto, Eiji Takeda and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1391-1396;

  9. Koyama, Eriko

    1. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes
      Takashi Kawashiro, Kouwa Yamashita, Xue-Jun Zhao, Eriko Koyama, Masayoshi Tani, Kan Chiba and Takashi Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1294-1300;

  10. Kuraishi, Yasushi

    1. Substance P Induction of Itch-Associated Response Mediated by Cutaneous NK1 Tachykinin Receptors in Mice
      Tsugunobu Andoh, Tetsuro Nagasawa, Masamichi Satoh and Yasushi Kuraishi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1140-1145;

L

  1. Lasheras, Berta

    1. The Role of Dopaminergic Systems in the Perinatal Sensitivity to 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rats
      Norberto Aguirre, Meritxell Barrionuevo, Berta Lasheras and Joaquín Del Río
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1159-1165;

  2. Lavielle, Gilbert

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;
    2. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  3. Lee, Chao-Pin

    1. Transport of l-Valine-Acyclovir Via the Oligopeptide Transporter In The Human Intestinal Cell Line, Caco-2
      Remco L. A. de Vrueh, Philip L. Smith and Chao-Pin Lee
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1166-1170;

  4. Lee, Stephanie

    1. Interaction of 2′,2′-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells
      Trisha Burke, Stephanie Lee, Peter J. Ferguson and James R. Hammond
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1333-1340;

  5. Lejeune, Françoise

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;

  6. Leza, Juan C.

    1. The Effects of Stress on Homeostasis in JCR-LA-cp Rats: The Role of Nitric Oxide
      Juan C. Leza, Eduardo Salas, Grzegorz Sawicki, James C. Russell and Marek W. Radomski
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1397-1403;

  7. Lluch, Salvador

    1. Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
      Gloria Segarra, Pascual Medina, Cristina Domenech, José M. Vila, Juan B. Martínez-León, Martín Aldasoro and Salvador Lluch
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1315-1320;

  8. Lorelli, William

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  9. Lowe, John

    1. Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A
      Sandra P. Welch, John W. Huffman and John Lowe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1301-1308;

  10. Luippold, Gerd

    1. Dopamine D2 Receptors Mediate Glomerular Hyperfiltration Due To Amino Acids
      Gerd Luippold and Bernd Mühlbauer
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1248-1252;

  11. Lydic, R.

    1. M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in the Medial Pontine Reticular Formation
      H. A. Baghdoyan, R. Lydic and M. A. Fleegal
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1446-1452;

M

  1. Martínez-León, Juan B.

    1. Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
      Gloria Segarra, Pascual Medina, Cristina Domenech, José M. Vila, Juan B. Martínez-León, Martín Aldasoro and Salvador Lluch
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1315-1320;

  2. Maurel-Remy, Sophie

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  3. Mavridis, Michaelis

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  4. Medina, Pascual

    1. Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
      Gloria Segarra, Pascual Medina, Cristina Domenech, José M. Vila, Juan B. Martínez-León, Martín Aldasoro and Salvador Lluch
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1315-1320;

  5. Medvedev, Ivan O.

    1. Effects of N-Methyl-d-Aspartate Receptor Antagonists on Discriminative Stimulus Effects of Naloxone in Morphine-Dependent Rats Using the Y-Maze Drug Discrimination Paradigm ,
      Ivan O. Medvedev, Olga A. Dravolina and Anton Y. Bespalov
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1260-1268;

  6. Mellor, Ian R.

    1. Potentiation and Inhibition of Nicotinic Acetylcholine Receptors by Spermine in the TE671 Human Muscle Cell Line
      Zuoyi Shao, Ian R. Mellor, Matthew J. Brierley, John Harris and Peter N. R. Usherwood
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1269-1276;

  7. Merkle, M.

    1. Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs
      L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger and W. Seeger
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1309-1314;

  8. Messer, W. S.

    1. Pharmacological Characterization of Human m1 Muscarinic Acetylcholine Receptors with Double Mutations at the Junction of TM VI and the Third Extracellular Domain
      X.-P. Huang, F. E. Williams, S. M. Peseckis and W. S. Messer
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1129-1139;

  9. Meyer, Urs

    1. Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin
      Gordon C. Ibeanu, Joyce A. Goldstein, Urs Meyer, Simone Benhamou, Christine Bouchardy, Pierre Dayer, Burhan I. Ghanayem and Joyce Blaisdell
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1490-1495;

  10. Millan, Mark J.

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;
    2. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  11. Miura, Nobuhiko

    1. Protective Effect of Bismuth Nitrate Against Injury to the Bone Marrow by γ-Irradiation in Mice: Possible Involvement of Induction of Metallothionein Synthesis
      Nobuhiko Miura, Masahiko Satoh, Nobumasa Imura and Akira Naganuma
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1427-1430;

  12. Miyamoto, Ken-Ichi

    1. Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
      Hikaru Yabuuchi, Ikumi Tamai, Kyoko Morita, Tomoko Kouda, Ken-Ichi Miyamoto, Eiji Takeda and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1391-1396;

  13. Monroe, Kimberly M.

    1. Dissociation of Angiotensin II-Stimulated Activation of Mitogen-Activated Protein Kinase Kinase from Vascular Contraction
      Stephanie W. Watts, Jennifer A. Florian and Kimberly M. Monroe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1431-1438;

  14. Morgan, Z. R.

    1. Calcium-Mediated Second Messengers Modulate the Expression of Behavioral Sensitization to Cocaine
      R. C. Pierce, E. A. Quick, D. C. Reeder, Z. R. Morgan and P. W. Kalivas
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1171-1176;

  15. Morita, Kyoko

    1. Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
      Hikaru Yabuuchi, Ikumi Tamai, Kyoko Morita, Tomoko Kouda, Ken-Ichi Miyamoto, Eiji Takeda and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1391-1396;

  16. Mousa, Shaker A.

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  17. Mühlbauer, Bernd

    1. Dopamine D2 Receptors Mediate Glomerular Hyperfiltration Due To Amino Acids
      Gerd Luippold and Bernd Mühlbauer
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1248-1252;

  18. Muller, Olivier

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;
    2. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  19. Mutlib, A. E.

    1. Application of Liquid Chromatography/Mass Spectrometry in Accelerating the Identification of Human Liver Cytochrome P450 Isoforms Involved in the Metabolism of Iloperidone
      A. E. Mutlib and J. T. Klein
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1285-1293;

N

  1. Naganuma, Akira

    1. Protective Effect of Bismuth Nitrate Against Injury to the Bone Marrow by γ-Irradiation in Mice: Possible Involvement of Induction of Metallothionein Synthesis
      Nobuhiko Miura, Masahiko Satoh, Nobumasa Imura and Akira Naganuma
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1427-1430;

  2. Nagasawa, Tetsuro

    1. Substance P Induction of Itch-Associated Response Mediated by Cutaneous NK1 Tachykinin Receptors in Mice
      Tsugunobu Andoh, Tetsuro Nagasawa, Masamichi Satoh and Yasushi Kuraishi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1140-1145;

  3. Nehlig, Astrid

    1. Modulation of Epileptiform Activity by Adenosine A1 Receptor-Mediated Mechanisms in the Juvenile Rat Hippocampus
      Virginia Tancredi, Margherita D’Antuono, Astrid Nehlig and Massimo Avoli
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1412-1419;

  4. Newman-Tancredi, Adrian

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;
    2. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  5. Nicolas, Jean-Paul

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;

O

  1. Okabe, Susumu

    1. Role of Cyclooxygenase-2 in the Healing of Gastric Ulcers in Rats
      Jun-Ichi Shigeta, Satoru Takahashi and Susumu Okabe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1383-1390;

  2. Okamura, Tomio

    1. Modifications by Superoxide-Generating Agent, Neurotransmitters and Neuromodulators of Nitroxidergic Nerve Function in Monkey Cerebral Arteries
      Tomio Okamura, Hideyuki Fujioka, Kazuhide Ayajiki and Noboru Toda
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1321-1325;

  3. Owyang, Chung

    1. Inhibitory Effects of Nitric Oxide Donors on Nitric Oxide Synthesis in Rat Gastric Myenteric Plexus
      Kenji Hosoda, Toku Takahashi, Masayuki A. Fujino and Chung Owyang
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1222-1230;

P

  1. Paalzow, Lennart K.

    1. Concentration-Effect Relationship of l-Propranolol and Metoprolol in Spontaneous Hypertensive Rats after Exercise-Induced Tachycardia
      Lena Brynne, Mats O. Karlsson and Lennart K. Paalzow
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1152-1158;

  2. Peseckis, S. M.

    1. Pharmacological Characterization of Human m1 Muscarinic Acetylcholine Receptors with Double Mutations at the Junction of TM VI and the Third Extracellular Domain
      X.-P. Huang, F. E. Williams, S. M. Peseckis and W. S. Messer
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1129-1139;

  3. Pierce, R. C.

    1. Calcium-Mediated Second Messengers Modulate the Expression of Behavioral Sensitization to Cocaine
      R. C. Pierce, E. A. Quick, D. C. Reeder, Z. R. Morgan and P. W. Kalivas
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1171-1176;

  4. Piercy, Marla

    1. Characterization of the Effects of the Partial Dopamine Agonist Terguride on Cocaine Self-Administration in the Rat
      Luigi Pulvirenti, Claudia Balducci, Marla Piercy and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1231-1238;

  5. Pierno, Sabata

    1. Chronic Administration of Taurine to Aged Rats Improves the Electrical and Contractile Properties of Skeletal Muscle Fibers
      Sabata Pierno, Annamaria De Luca, Claudia Camerino, Ryan J. Huxtable and Diana Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1183-1190;

  6. Pond, Amber L.

    1. Purification of Two Rat Hepatic Proteins with A-Esterase Activity Toward Chlorpyrifos-Oxon and Paraoxon
      Amber L. Pond, Howard W. Chambers, Cody P. Coyne and Janice E. Chambers
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1404-1411;

  7. Pulvirenti, Luigi

    1. Characterization of the Effects of the Partial Dopamine Agonist Terguride on Cocaine Self-Administration in the Rat
      Luigi Pulvirenti, Claudia Balducci, Marla Piercy and George F. Koob
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1231-1238;

Q

  1. Quick, E. A.

    1. Calcium-Mediated Second Messengers Modulate the Expression of Behavioral Sensitization to Cocaine
      R. C. Pierce, E. A. Quick, D. C. Reeder, Z. R. Morgan and P. W. Kalivas
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1171-1176;

  2. Quilley, John

    1. Evidence against Anandamide as the Hyperpolarizing Factor Mediating the Nitric Oxide-Independent Coronary Vasodilator Effect of Bradykinin in the Rat
      David Fulton and John Quilley
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1146-1151;

R

  1. Radomski, Marek W.

    1. The Effects of Stress on Homeostasis in JCR-LA-cp Rats: The Role of Nitric Oxide
      Juan C. Leza, Eduardo Salas, Grzegorz Sawicki, James C. Russell and Marek W. Radomski
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1397-1403;

  2. Reeder, D. C.

    1. Calcium-Mediated Second Messengers Modulate the Expression of Behavioral Sensitization to Cocaine
      R. C. Pierce, E. A. Quick, D. C. Reeder, Z. R. Morgan and P. W. Kalivas
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1171-1176;

  3. Reilly, Thomas M.

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  4. Ring, Barbara J.

    1. Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
      Sean Ekins, Mark Vandenbranden, Barbara J. Ring, Jennifer S. Gillespie, Tian J. Yang, Harry V. Gelboin and Steven A. Wrighton
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1253-1259;

  5. Rivet, Jean-Michel

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: I. Receptorial and Neurochemical Profile in Comparison with Clozapine and Haloperidol
      Mark J. Millan, Alain Gobert, Adrian Newman-Tancredi, Valérie Audinot, Françoise Lejeune, Jean-Michel Rivet, Didier Cussac, Jean-Paul Nicolas, Olivier Muller and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1341-1355;
    2. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  6. Ruffolo, Robert R.

    1. CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
      Miklos Gellai, George F. Schreiner, Robert R. Ruffolo, Tracey Fletcher, Robin DeWolf and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1191-1196;

  7. Russell, James C.

    1. The Effects of Stress on Homeostasis in JCR-LA-cp Rats: The Role of Nitric Oxide
      Juan C. Leza, Eduardo Salas, Grzegorz Sawicki, James C. Russell and Marek W. Radomski
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1397-1403;

S

  1. Sadeghi, Parvine

    1. Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Pentazocine and Morphine in Normal Volunteers
      James P. Zacny, Joanna L. Hill, Matthew L. Black and Parvine Sadeghi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1197-1207;

  2. Salas, Eduardo

    1. The Effects of Stress on Homeostasis in JCR-LA-cp Rats: The Role of Nitric Oxide
      Juan C. Leza, Eduardo Salas, Grzegorz Sawicki, James C. Russell and Marek W. Radomski
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1397-1403;

  3. Satoh, Masahiko

    1. Protective Effect of Bismuth Nitrate Against Injury to the Bone Marrow by γ-Irradiation in Mice: Possible Involvement of Induction of Metallothionein Synthesis
      Nobuhiko Miura, Masahiko Satoh, Nobumasa Imura and Akira Naganuma
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1427-1430;

  4. Satoh, Masamichi

    1. Substance P Induction of Itch-Associated Response Mediated by Cutaneous NK1 Tachykinin Receptors in Mice
      Tsugunobu Andoh, Tetsuro Nagasawa, Masamichi Satoh and Yasushi Kuraishi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1140-1145;

  5. Sawicki, Grzegorz

    1. The Effects of Stress on Homeostasis in JCR-LA-cp Rats: The Role of Nitric Oxide
      Juan C. Leza, Eduardo Salas, Grzegorz Sawicki, James C. Russell and Marek W. Radomski
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1397-1403;

  6. Schölkens, Bernward A.

    1. HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part I: Effects on Cardiomyocytes, Coronary Flow and Pancreatic β-Cells
      Heinz Gögelein, Jens Hartung, Heinrich C. Englert and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1453-1464;
    2. HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part II: Effects on Susceptibility to Ventricular Fibrillation Induced by Myocardial Ischemia in Conscious Dogs
      George E. Billman, Heinrich C. Englert and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1465-1473;

  7. Schreiber, Rudy

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  8. Schreiner, George F.

    1. CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity
      Miklos Gellai, George F. Schreiner, Robert R. Ruffolo, Tracey Fletcher, Robin DeWolf and David P. Brooks
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1191-1196;

  9. Sebban, Claude

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

  10. Seeger, W.

    1. Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs
      L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger and W. Seeger
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1309-1314;

  11. Segarra, Gloria

    1. Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
      Gloria Segarra, Pascual Medina, Cristina Domenech, José M. Vila, Juan B. Martínez-León, Martín Aldasoro and Salvador Lluch
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1315-1320;

  12. Shao, Zuoyi

    1. Potentiation and Inhibition of Nicotinic Acetylcholine Receptors by Spermine in the TE671 Human Muscle Cell Line
      Zuoyi Shao, Ian R. Mellor, Matthew J. Brierley, John Harris and Peter N. R. Usherwood
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1269-1276;

  13. Shigeta, Jun-Ichi

    1. Role of Cyclooxygenase-2 in the Healing of Gastric Ulcers in Rats
      Jun-Ichi Shigeta, Satoru Takahashi and Susumu Okabe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1383-1390;

  14. Silverman, Jeffrey A.

    1. Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein
      Annice E. Kim, Jay M. Dintaman, David S. Waddell and Jeffrey A. Silverman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1439-1445;

  15. Sims, Stephen M.

    1. Hydrogen Peroxide-Induced Stimulation of L-Type Calcium Current in Guinea Pig Ventricular Myocytes and Its Inhibition by Adenosine A1 Receptor Activation
      George P. Thomas, Stephen M. Sims, Michael A. Cook and Morris Karmazyn
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1208-1214;

  16. Slee, Andrew M.

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  17. Smith, Maree T.

    1. Apparent Insensitivity of the Hotplate Latency Test for Detection of Antinociception Following Intraperitoneal, Intravenous or Intracerebroventricular M6G Administration to Rats
      Samantha M. South and Maree T. Smith
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1326-1332;

  18. Smith, Philip L.

    1. Transport of l-Valine-Acyclovir Via the Oligopeptide Transporter In The Human Intestinal Cell Line, Caco-2
      Remco L. A. de Vrueh, Philip L. Smith and Chao-Pin Lee
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1166-1170;

  19. South, Samantha M.

    1. Apparent Insensitivity of the Hotplate Latency Test for Detection of Antinociception Following Intraperitoneal, Intravenous or Intracerebroventricular M6G Administration to Rats
      Samantha M. South and Maree T. Smith
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1326-1332;

  20. Spedding, Michael

    1. S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
      Mark J. Millan, Rudy Schreiber, Anne Dekeyne, Jean-Michel Rivet, Karin Bervoets, Michaelis Mavridis, Claude Sebban, Sophie Maurel-Remy, Adrian Newman-Tancredi, Michael Spedding, Olivier Muller, Gilbert Lavielle and Mauricette Brocco
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1356-1373;

T

  1. Takahashi, Satoru

    1. Role of Cyclooxygenase-2 in the Healing of Gastric Ulcers in Rats
      Jun-Ichi Shigeta, Satoru Takahashi and Susumu Okabe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1383-1390;

  2. Takahashi, Toku

    1. Inhibitory Effects of Nitric Oxide Donors on Nitric Oxide Synthesis in Rat Gastric Myenteric Plexus
      Kenji Hosoda, Toku Takahashi, Masayuki A. Fujino and Chung Owyang
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1222-1230;

  3. Takeda, Eiji

    1. Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
      Hikaru Yabuuchi, Ikumi Tamai, Kyoko Morita, Tomoko Kouda, Ken-Ichi Miyamoto, Eiji Takeda and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1391-1396;

  4. Tamai, Ikumi

    1. Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
      Hikaru Yabuuchi, Ikumi Tamai, Kyoko Morita, Tomoko Kouda, Ken-Ichi Miyamoto, Eiji Takeda and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1391-1396;

  5. Tancredi, Virginia

    1. Modulation of Epileptiform Activity by Adenosine A1 Receptor-Mediated Mechanisms in the Juvenile Rat Hippocampus
      Virginia Tancredi, Margherita D’Antuono, Astrid Nehlig and Massimo Avoli
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1412-1419;

  6. Tani, Masayoshi

    1. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes
      Takashi Kawashiro, Kouwa Yamashita, Xue-Jun Zhao, Eriko Koyama, Masayoshi Tani, Kan Chiba and Takashi Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1294-1300;

  7. Thomas, George P.

    1. Hydrogen Peroxide-Induced Stimulation of L-Type Calcium Current in Guinea Pig Ventricular Myocytes and Its Inhibition by Adenosine A1 Receptor Activation
      George P. Thomas, Stephen M. Sims, Michael A. Cook and Morris Karmazyn
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1208-1214;

  8. Thoolen, Martin J. M. C.

    1. Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3
      Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Mark S. Forsythe, Martin J. M. C. Thoolen, Andrew M. Slee, Thomas M. Reilly and Paul A. Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1277-1284;

  9. Toda, Noboru

    1. Modifications by Superoxide-Generating Agent, Neurotransmitters and Neuromodulators of Nitroxidergic Nerve Function in Monkey Cerebral Arteries
      Tomio Okamura, Hideyuki Fujioka, Kazuhide Ayajiki and Noboru Toda
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1321-1325;

  10. Tsuji, Akira

    1. Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
      Hikaru Yabuuchi, Ikumi Tamai, Kyoko Morita, Tomoko Kouda, Ken-Ichi Miyamoto, Eiji Takeda and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1391-1396;

U

  1. Usherwood, Peter N. R.

    1. Potentiation and Inhibition of Nicotinic Acetylcholine Receptors by Spermine in the TE671 Human Muscle Cell Line
      Zuoyi Shao, Ian R. Mellor, Matthew J. Brierley, John Harris and Peter N. R. Usherwood
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1269-1276;

V

  1. Vallon, Volker

    1. Effect of KATP Channel Blocker U37883A on Renal Function in Experimental Diabetes Mellitus in Rats
      Volker Vallon, Margitta Albinus and Doreen Blach
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1215-1221;

  2. Vandenbranden, Mark

    1. Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
      Sean Ekins, Mark Vandenbranden, Barbara J. Ring, Jennifer S. Gillespie, Tian J. Yang, Harry V. Gelboin and Steven A. Wrighton
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1253-1259;

  3. Vila, José M.

    1. Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels
      Gloria Segarra, Pascual Medina, Cristina Domenech, José M. Vila, Juan B. Martínez-León, Martín Aldasoro and Salvador Lluch
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1315-1320;

W

  1. Waddell, David S.

    1. Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein
      Annice E. Kim, Jay M. Dintaman, David S. Waddell and Jeffrey A. Silverman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1439-1445;

  2. Wang, Hoau-Yan

    1. Serotonin-Mediated Palmitoylation and Depalmitoylation of GAlpha Proteins in Rat Brain Cortical Membranes
      Shubhada Bhamre, Hoau-Yan Wang and Eitan Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1482-1489;

  3. Watts, Stephanie W.

    1. Dissociation of Angiotensin II-Stimulated Activation of Mitogen-Activated Protein Kinase Kinase from Vascular Contraction
      Stephanie W. Watts, Jennifer A. Florian and Kimberly M. Monroe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1431-1438;

  4. Welch, Sandra P.

    1. Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A
      Sandra P. Welch, John W. Huffman and John Lowe
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1301-1308;

  5. Weller, Michael

    1. Potentiation of CD95L-Induced Apoptosis of Human Malignant Glioma Cells by Topotecan Involves Inhibition of RNA Synthesis but Not Changes in CD95 or CD95L Protein Expression
      Stephan Winter and Michael Weller
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1374-1382;

  6. Wennberg, Richard

    1. Multiple Actions of Methohexital on Hippocampal CA1 and Cortical Neurons of Rat Brain Slices
      Liang Zhang, Yu Zhang and Richard Wennberg
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1177-1182;

  7. Williams, F. E.

    1. Pharmacological Characterization of Human m1 Muscarinic Acetylcholine Receptors with Double Mutations at the Junction of TM VI and the Third Extracellular Domain
      X.-P. Huang, F. E. Williams, S. M. Peseckis and W. S. Messer
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1129-1139;

  8. Winter, Stephan

    1. Potentiation of CD95L-Induced Apoptosis of Human Malignant Glioma Cells by Topotecan Involves Inhibition of RNA Synthesis but Not Changes in CD95 or CD95L Protein Expression
      Stephan Winter and Michael Weller
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1374-1382;

  9. Wrighton, Steven A.

    1. Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
      Sean Ekins, Mark Vandenbranden, Barbara J. Ring, Jennifer S. Gillespie, Tian J. Yang, Harry V. Gelboin and Steven A. Wrighton
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1253-1259;

Y

  1. Yabuuchi, Hikaru

    1. Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
      Hikaru Yabuuchi, Ikumi Tamai, Kyoko Morita, Tomoko Kouda, Ken-Ichi Miyamoto, Eiji Takeda and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1391-1396;

  2. Yamashita, Kouwa

    1. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes
      Takashi Kawashiro, Kouwa Yamashita, Xue-Jun Zhao, Eriko Koyama, Masayoshi Tani, Kan Chiba and Takashi Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1294-1300;

  3. Yang, Tian J.

    1. Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
      Sean Ekins, Mark Vandenbranden, Barbara J. Ring, Jennifer S. Gillespie, Tian J. Yang, Harry V. Gelboin and Steven A. Wrighton
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1253-1259;

Z

  1. Zacny, James P.

    1. Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Pentazocine and Morphine in Normal Volunteers
      James P. Zacny, Joanna L. Hill, Matthew L. Black and Parvine Sadeghi
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1197-1207;

  2. Zeng, Li

    1. EP4/EP2 Receptor-Specific Prostaglandin E2 Regulation of Interleukin-6 Generation by Human HSB.2 Early T Cells
      Li Zeng, Songzhu An and Edward J. Goetzl
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1420-1426;

  3. Zhang, Liang

    1. Multiple Actions of Methohexital on Hippocampal CA1 and Cortical Neurons of Rat Brain Slices
      Liang Zhang, Yu Zhang and Richard Wennberg
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1177-1182;

  4. Zhang, Yu

    1. Multiple Actions of Methohexital on Hippocampal CA1 and Cortical Neurons of Rat Brain Slices
      Liang Zhang, Yu Zhang and Richard Wennberg
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1177-1182;

  5. Zhao, Xue-Jun

    1. A Study on the Metabolism of Etoposide and Possible Interactions with Antitumor or Supporting Agents by Human Liver Microsomes
      Takashi Kawashiro, Kouwa Yamashita, Xue-Jun Zhao, Eriko Koyama, Masayoshi Tani, Kan Chiba and Takashi Ishizaki
      Journal of Pharmacology and Experimental Therapeutics September 1998, 286 (3) 1294-1300;
Back to top

In this issue